ExpreS2ion Biotech Stock

Detail Data
Volume (24h): 1,485 shares
P/E Ratio: /
Forward P/E: -0.83
EPS: -21.54 SEK
Forward EPS: -22.39 SEK
Number of Shares: 2,658,350 shares
Market Capitalization: 49,179,476.00 SEK

Dividend

Dividend Value
Dividend Amount According to our data, the company ExpreS2ion Biotech does not currently pay dividends.
Annual Yield %: -
Ex-dividend Date: -
5-Year Avg Yield %: -
Payout Ratio: -
Last Dividend Value: -
Last Dividend Date: -

Analyst Forecast

Most analysts have issued a none recommendation for ExpreS2ion Biotech stock. The current number of analysts covering this company is 1. The highest target price is 303 SEK, while the lowest target price is 303 SEK. The median target valuation set by analysts is 303 SEK. These forecasts and recommendations provide insight into how analysts view the future stock performance of ExpreS2ion Biotech.
Analysts Recommendation
Issued Recommendation: According to our data, the recommendation for ExpreS2ion Biotech stock is: none
Number of Analysts: 1
Highest Target Price: 303 SEK
Lowest Target Price: 303 SEK
Median Target Price: 303 SEK

Fundamental Indicators

Indicator Data
Total Revenue: 7,825,000.00 SEK
Net Income: -36,415,000.00 SEK
Price-to-Book (P/B): 0.76
PEG Ratio: /
Exchange: Stockholm
Industry: Biotechnology
Sector: Healthcare
Number of Employees: 18
Country: Sweden

Where to Buy ExpreS2ion Biotech Stock?

You can purchase ExpreS2ion Biotech stock on the Stockholm under the ticker symbol: EXPRS2.ST. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

1

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.

Trustpilot rating 4.4/5 Google play rating 4.2/5
Invest in Stocks with eToro
★★★★★ 5.0
2

Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.

Trustpilot rating 3.6/5 Google play rating 4.5/5
Try Free Demo Account
★★★★☆ 4.8
Risk warning: Trading CFDs involves a high risk of financial loss. Between 51%-eToro -89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

More Information on ExpreS2ion Biotech Stock

Indicator Value
Company Revenue: 7,825,000.00 SEK
EBITDA: -66,054,000.00 SEK - Negative EBITDA may signal financial challenges or growth investments.
Earnings Per Share: -21.54 SEK
Book Value Per Share: 24.23 SEK
Total Cash: 81,541,000.00 SEK
Total Cash per Share: 30.67 SEK
Total Debt: 1,797,000.00 SEK
Debt to Equity Ratio: 0.03
Quick Ratio 2.45
Current Ratio 2.48
Free Cash Flow -17,583,750.00 SEK
Operating Cash Flow -33,928,000.00 SEK
Gross Margins 27.40 %
EBITDA Margins -
Operating Margins -904.50 %
Profit Margins -
Return on Assets -46.2 %
Return on Equity -56.1 %
Earnings Growth (1 year) -
Revenue Growth (1 year) -4.6 %
Quarterly Earnings Year-over-Year Growth -
Market Capitalization 49,179,476.00 SEK
Enterprise Value -29,235,426.00 SEK
EV/Revenue -3.736
EV/EBITDA 0.443
Float Shares 2,644,390 shares
Shares Outstanding 2,658,350 shares
Held Percent Insiders -
Held Percent Institutions 4.16 %
Shares Short -
Shares Short Prior Month -
Date Short Interest -
Short Percentage of Total Shares -
Short Ratio -
Beta 2.71
Short Percentage of Float -
Implied Shares Outstanding 2,739,080

Frequently Asked Questions (FAQ)

According to our data, the company ExpreS2ion Biotech does not pay dividends yet, even in 2025.

ExpreS2ion Biotech shares are traded on the Stockholm stock exchange under the ticker: EXPRS2.ST. You can buy or trade them through a variety of stock brokers who provide real stock trading services.

According to our data, the recommendation for ExpreS2ion Biotech shares is from a total of 1 analysts. The average target price prediction is 303 SEK per share.

The total number of ExpreS2ion Biotech shares on the exchange is 2,658,350.00 shares, which at the current market capitalization gives the company a total valuation of 49,179,476.00 SEK.